Differentiating Symptoms of Panic from Relapse of Guillain-Barré Syndrome

REFERENCES

• Lennon SM, Koblar S, Hughes RAC, Goeller J, Riser AC. Rea- sons for persistent disability in Guillain-Barre´ syndrome. Clin Rehab 1993;7:1–8.
   Google Scholar
• Ropper AH. The Guillain-Barre´ syndrome. N Engl J Med 1992;326:1130–6.
   PubMed Web of Science ®Google Scholar
• DiNardo PA, Brown TA, Barlow DH. Anxiety Disorders Inter- view Schedule for DSM-IV (Lifetime version). San Antonio, Texas: Psychological Corporation, 1995.
   Google Scholar
• Chambless DL, Caputo GC, Bright P, Gallagher R. Assess- ment of fear in agoraphobics: the Body Sensations Question- naire and the Agoraphobic Cognitions Questionnaire. J Con- sult Clin Psychol 1984;52:1090–7.
   PubMed Web of Science ®Google Scholar
• Ince LP, Brenes Jette CC. EMG biofeedback to patients with Guillain-Barre´ syndrome. Rehab Psychol 1987;32:155–63.
   Google Scholar
• Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylo- bacter jejuni infection and Guillain-Barre´ syndrome. N Engl J Med 1995;333:1374–9.
   PubMed Web of Science ®Google Scholar
• Manelis ZS. Etiology and pathogenesis of polyneuritis: review of the literature [In Russian with an English abstract]. Zh Ne- vropatol Psikhiatr Im S S Korsakova 1986;86:1720–6.
   Google Scholar
• Van der Meche FGA, Schmitz PIM. A randomized trial com- paring intravenous immune globulin and plasma exchange in Guillain-Barre´ syndrome. N Engl J Med 1992;326:1123–9.
   Google Scholar
• Weis H. Psychic changes in patients with acute Guillain-Barre´ syndrome: psychological aspects and coping with loss of com- munication [In German with an English abstract.]. Fortschr Neurol Psychiatr 1991;59:134–40.
   Google Scholar
• Eisendrath SJ, Matthay MA, Dunkel JA, Zimmerman JK, Layzer RB. Guillain-Barre´ syndrome: psychosocial aspects of management. Psychosomatics 1983;24:465–75.
   PubMed Web of Science ®Google Scholar
• Bernsen RA, De Jager AE, Schmitz PI, Van der Meche FG. Residual physical outcome in daily living 3 to 6 years after Guillain-Barre´ syndrome. Neurology 1999;53:409–410.
   PubMed Web of Science ®Google Scholar
• Reiss S. Expectancy model of fear, anxiety and panic. Clin Psy- chol Rev 1991;11:141–53.
   Web of Science ®Google Scholar
• Bradley BP, Mogg K, Millar N, White J. Selective process- ing of negative information: effects of clinical anxiety, concur- rent depression, and awareness. J Abnorm Psychol 1995;104:532–6.
   PubMed Web of Science ®Google Scholar
• Dattilio FM. Cognitive-behavioral treatment of panic compli- cated by medical illness. Psychotherapy [In press].
   Google Scholar
• Dattilio FM, Salas-Auvert J. Panic attack or heart attack? Anx Disord Assoc America Newsl 1999;1(4):5–21.
   Google Scholar
• Teitelbaum ML, Kettl P. Brief psychotherapy with a patient suffering from Guillain-Barre´ syndrome. Psychosomatics 1988;29:231–3.
   Google Scholar
• Wherry JN, McMillan SL, Hutchison HT. Differential diagno- sis and treatment of conversion disorder and Guillain-Barre´ syndrome. Clin Pediatr 1991;30:578–82.
   Google Scholar
• Chemtob CM, Herriott MG. Post-traumatic stress disorder as a sequela of Guillain-Barre´ syndrome. J Trauma Stress 1994; 7:705–11.
   Google Scholar
• Pecknold JC. Serotonin abnormalities in panic disorder. In: Ballenger JC, ed. Neurobiology of panic disorder. (Frontiers of clinical neuroscience, vol 8.) New York: Wiley-Liss, 1990: 121–42.
   Google Scholar
• Iversen SD. 5-HT and anxiety. Neuropharmacology 1984;23:1553–60.
   PubMed Web of Science ®Google Scholar
• Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroana- tomical hypothesis of panic disorder, revised. Am J Psychiatry 2000;157:493–505.
   PubMed Web of Science ®Google Scholar
• Boyer W. Serotonin uptake inhibitors are superior to imipra- mine and alprazolam in alleviating panic attacks: a meta- analysis. Int Clin Psychopharmacol 1995;10:45–9.
   PubMed Web of Science ®Google Scholar
• Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive- behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000; 283:2529–36.
   PubMed Web of Science ®Google Scholar
• Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Da- vies SR, et al. Alprazolam in the treatment of panic disorders. J Clin Psychopharmacol 1986;6:13–20.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Ballenger J, Jacobsen G. Treatment of endoge- nous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51–9.
   PubMed Web of Science ®Google Scholar
• Rachman SJ. Fear and courage. 2nd ed. New York: Freeman, 1990.
   Google Scholar
• Katon W. Panic disorder in the medical setting. Rockville, Maryland: National Institute of Mental Health, 1992.
   Google Scholar
• Cottraux J, Note ID, Cungi C, Le´geron P, Heim F, Chneiweiss L, et al. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. Br J Psychiatry 1995;167:635–41.
   PubMedGoogle Scholar
• Klosko JS, Barlow DH, Tassinari R, Cerny JA. A comparison of alprazolam and behavior therapy in the treatment of panic disorder. J Consult Clin Psychol 1990;58:77–84.
   PubMed Web of Science ®Google Scholar
• Dattilio FM. Symptom induction and de-escalation in the treatment of panic attacks. J Ment Health Couns 1990;12:515–9.
   Google Scholar
• Dattilio FM, Salas-Auvert JA. Panic disorder: assessment and treatment through a wide-angle lens. Phoenix: Zeig, Tucker, 2000.
   Google Scholar
• Sanderson WC, Rego SA. Empirically supported treatment for panic disorder: research, theory and application of cognitive behavioral therapy. J Cogn Psychother 2000;14:219–44.
   Google Scholar
• Penava SJ, Otto MW, Maki KM, Pollack MH. Rate of improve- ment during cognitive-behavioral group treatment for panic disorder. Behav Res Ther 1998;36:665–73.
   PubMedGoogle Scholar
• Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995;166:87–92.
   PubMed Web of Science ®Google Scholar
• Craske MG, Brown TA, Barlow DH. Behavioral treatment of panic disorder: a two-year follow-up. Behav Ther 1991;22:289–304.
   Web of Science ®Google Scholar
• Margraf J, Barlow DH, Clark DM, Telch MJ. Psychological treatment of panic: work in progress on outcome, active ingre- dients, and follow-up. Behav Res Ther 1993;31:1–8.
   PubMed Web of Science ®Google Scholar
• Pollack MH, Otto MW, Kaspi SP, Hammerness PG, Rosen- baum JF. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry 1994;55:200–5.
   Google Scholar
• Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anas- tasiades P, Gelder M. A comparison of cognitive therapy, ap- plied relaxation and imipramine in the treatment of panic dis- order. Br J Psychiatry 1994;164:759–69.
   Google Scholar
• Clum GA. Coping with panic: a drug-free approach to dealing with anxiety attacks. Pacific Grove, California: Brooks/Cole, 1990.
   Google Scholar
• Gitlin B, Martin J, Shear MK, Frances A, Ball G, Joseph- son S. Behavior therapy for panic disorder. J Nerv Ment Dis 1985;173:742–3.
   PubMed Web of Science ®Google Scholar
• Beck AT, Sokol L, Clark DA, Berchick R, Wright F. A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry 1992;149:778–83.
   PubMed Web of Science ®Google Scholar